导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -29.69% | 338/354 |
| 近一周 | -3.69% | 291/362 |
| 近一月 | -8.21% | 294/362 |
| 近一季 | -8.29% | 281/362 |
| 近半年 | -19.21% | 341/358 |
| 近一年 | -38.02% | 339/349 |
| 近两年 | -0.25% | 302/314 |
| 近三年 | -7.17% | 229/246 |
| 成立以来 | 8.67% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-19.04% 341/360 |
-13.12% 299/366 |
- - |
- - |
| 2025 | 18.91% 142/358 |
17.17% 83/340 |
-2.13% 270/348 |
21.10% 59/354 |
-14.37% 259/358 |
| 2024 | 13.63% 171/329 |
-2.08% 184/280 |
4.16% 118/310 |
23.96% 76/318 |
-10.12% 284/329 |
| 2023 | -7.44% 122/275 |
1.30% 125/205 |
-8.79% 184/230 |
-1.02% 16/262 |
1.21% 149/276 |
| 2022 | -5.94% 29/201 |
-16.78% 109/153 |
16.42% 3/164 |
-18.29% 116/189 |
18.81% 17/202 |
| 2021 | -46.55% 100/150 |
-0.30% 217/312 |
-9.10% 306/328 |
-29.68% 321/358 |
-16.13% 140/151 |
| 2020 | 46.71% 5/103 |
-5.32% 78/280 |
35.05% 19/295 |
4.91% 99/299 |
9.37% 135/305 |
| 2019 | 30.22% 19/88 |
20.89% 14/258 |
-4.94% 243/268 |
-2.43% 189/253 |
16.14% 12/266 |
| 2018 | -25.47% 66/79 |
- - |
- - |
- - |
-18.32% 204/241 |
| 2017 | 49.25% 2/69 |
- - |
- - |
- - |
- - |
| 2016 | -3.41% 43/59 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 交银中证海外中国互联网指数(LOF)A VS. 建信富时100指数(QDII)人民币A(539003) |